SCHEMBL7041582

SCHEMBL7041582

CCc1cc(Nc2cc(=O)n(CCCCN3CCN(c4nc(C)cc(C(=O)O)n4)CC3)c(=O)[nH]2)ccc1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7040821 0.92 — —
SCHEMBL7111268 0.84 — —
SCHEMBL3478672 0.82 — —
SCHEMBL6903111 0.82 — —
SCHEMBL3471013 0.81 — —
SCHEMBL6902934 0.80 — —
SCHEMBL6780269 0.80 — —
SCHEMBL11997019 0.80 — —
SCHEMBL6782994 0.79 — —
SCHEMBL6784732 0.79 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030114445-A1 N3-substituted 6-anilinopyrimidines and methods to treat-Gram-positive bacterial and mycoplasmal infections NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2003-06-19 — — US disclosed
WO-2003011297-A1 N3-SUBSTITUTED 6-ANILINOPYRIMIDINES AND METHODS TO TREAT GRAM-POSITIVE BACTERIAL AND MYCOPLASMAL INFECTIONS UNIVERSITY OF MASSACHUSETTS (US) 2003-02-13 — — WO disclosed
Send feedback